Skip to main content

Profound Medical Corp.

PROF
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001628808

No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Profound Medical Corp. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of PROF: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders3145+14
Shares7.49M9.25M+1.76M (+23.5%)
Value$75.5M$77.8M+$2.29M (+3.0%)

New holders (16)

Institutions that held Profound Medical Corp. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to PROF in Q4 2023
InstitutionSharesValue% of portfolio
AIGH Capital Management LLC646,733$5.49M2.17%
Rosalind Advisors, Inc.533,333$4.53M3.79%
Worth Venture Partners, LLC160,971$1.37M0.74%
Bleichroeder LP133,333$1.13M0.25%
Kepos Capital LP100,000$849.0K0.28%
Silvercrest Asset Management Group LLC67,001$568.8K0.00%
Renaissance Technologies LLC21,900$186.0K0.00%
Northwest & Ethical Investments L.P.17,400$145.8K0.00%
Chilton Investment Co LLC10,000$84.9K0.00%
Levin Capital Strategies, L.P.10,000$84.9K0.01%
FNY Investment Advisers, LLC8,000$67.0K0.08%
Wetzel Investment Advisors, Inc.2,000$17.0K0.01%
JPMorgan Chase & Co1,503$12.8K0.00%
Tower Research Capital LLC (TRC)415$3.52K0.00%
Cape Investment Advisory, Inc.231$1.96K0.00%
Toronto Dominion Bank38$3230.00%

Sold out (2)

Institutions that held Profound Medical Corp. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of PROF in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Harbor Advisors LLC12,400$126.5K
Group One Trading, L.P.99$1.01K